Autosomal dominant polycystic kidney disease V. E. TORRES , P. C. HARRIS

The safety and efficacy of tolvaptan in the treatment of patients with autosomal dominant polycystic kidney disease: A systematic review and meta-analysis Xuanwei Li, Wenlai Li, Yue Li, Chuanjiang Dong, Ping Zhu

Chronic pancreatitis with polycystic kidney disease: A rare coincidence? Gabriela Hrčková, Eszter Hegyi, Katarína Skalická, Iveta Čierna, Tomáš Dallos, Denisa Ilenčíková